| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Assay Aids Diagnosis of Resistant Hypertension
Answers From the Lab
About 20% of people taking antihypertensive medications aren't meeting their targeted blood pressure levels. In this test-specific episode of the "Answers From the Lab" podcast, John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' new assay can help clinicians evaluate individuals with resistant hypertension to meet blood pressure goals.
"One reason for resistant hypertension is that people aren't able to take their medications for some reason. That can be difficult to figure out clinically. But most of these drugs are eliminated by the kidneys and appear in urine," Dr. Lieske says.
Mayo Clinic Laboratories' mass spectrometry assay can detect the presence of 16 common antihypertensive drugs in patients' urine samples. Test results can spur clinical discussions of why patients aren't taking their medications, further evaluation to determine if medications aren't being properly absorbed for some reason, and potentially, new treatment plans.
"Patients with resistant hypertension have higher rates of cardiovascular complications and are more likely to have underlying or secondary causes of their hypertension," Dr. Taler says. "Studies indicate that the rate of nonadherence to antihypertensive medications is higher than we thought. There really is a role for monitoring antihypertensive drugs in body fluids."
Listen to learn more about Mayo Clinic Laboratories' hypertension assay.
Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
